Securian Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Securian Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-13,322	Closed	-$718K	–	1022
2017 Q4	$718K	Sell	13,322 -332	-2%	-$18.2K	0.02%	670
2017 Q3	$779K	Hold	13,654	–	–	0.02%	605
2017 Q2	$822K	Sell	13,654 -168	-1%	-$9.57K	0.02%	587
2017 Q1	$753K	Buy	+13,822	New	+$681K	0.02%	613

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Securian Asset Management's BIVV Position: Q1 2018 in Review

Securian Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 13,322 shares — an estimated $718K sold.

Securian Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $822K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Securian Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Securian Asset Management sold 13,322 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $718K.
Securian Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Securian Asset Management's Bioverativ Inc. Common Stock position peaked at $822K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Securian Asset Management's 13F filing for Q1 2018, filed 30 Apr 2018.